We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+10.57%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$39.7B
AUM Growth
+$3.75B
(+10%)
Cap. Flow
-$158M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
15.03%
Holding
2,331
New
307
Increased
917
Reduced
752
Closed
230
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackrock
BLK
|
+$174M |
| 2 |
Equinix
EQIX
|
+$155M |
| 3 |
Dynatrace
DT
|
+$140M |
| 4 |
Xcel Energy
XEL
|
+$131M |
| 5 |
Merck
MRK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$236M |
| 2 |
TSMC
TSM
|
+$232M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$212M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$161M |
| 5 |
Salesforce
CRM
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Consumer Discretionary | 12.46% |
| 3 | Financials | 12.1% |
| 4 | Healthcare | 11.52% |
| 5 | Industrials | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Praxis Precision Medicines
PRAX
$9.07B
| $971K | ﹤0.01% |
15,921
+2,782
| +21% | +$125K |
|
1452
Fulcrum Therapeutics
FULC
$248M
| $965K | ﹤0.01% |
102,226
+7,609
| +8% | +$67.9K |
|
1453
Goosehead Insurance
GSHD
$1.39B
| $962K | ﹤0.01% |
14,435
-4,065
| -22% | -$311K |
|
1454
Seer Inc
SEER
$108M
| $960K | ﹤0.01% |
505,215
+201,275
| +66% | +$361K |
|
1455
Groupon
GRPN
$980M
| $958K | ﹤0.01% |
71,807
+11,570
| +19% | +$176K |
|
1456
Levi Strauss
LEVI
$9.44B
| $955K | ﹤0.01% |
47,795
-62,955
| -57% | -$1.09M |
|
1457
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
| $953K | ﹤0.01% |
20,520
-58,380
| -74% | -$2.51M |
|
1458
First Financial Corp
THFF
$922M
| $951K | ﹤0.01% |
24,815
+18,320
| +282% | +$710K |
|
1459
AtriCure
ATRC
$1.77B
| $951K | ﹤0.01% |
+31,262
| New | +$1.05M |
|
1460
Upland Software
UPLD
$12M
| $951K | ﹤0.01% |
30,766
+9,401
| +44% | +$341K |
|
1461
The RealReal
REAL
$1.34B
| $950K | ﹤0.01% |
242,883
-34,570
| -12% | -$82.4K |
|
1462
Nuvation Bio
NUVB
$2.24B
| $947K | ﹤0.01% |
260,279
+21,949
| +9% | +$42.1K |
|
1463
Aquestive Therapeutics
AQST
$462M
| $946K | ﹤0.01% |
+222,086
| New | +$739K |
|
1464
Revolution Medicines
RVMD
$40.2B
| $944K | ﹤0.01% |
+29,297
| New | +$868K |
|
1465
BlueLinx
BXC
$455M
| $944K | ﹤0.01% |
+7,249
| New | +$852K |
|
1466
Visteon
VC
$2.77B
| $939K | ﹤0.01% |
7,986
-16,442
| -67% | -$1.92M |
|
1467
Liberty Live Group Series C
LLYVK
$9.11B
| $939K | ﹤0.01% |
21,431
+1,993
| +10% | +$76.3K |
|
1468
Xerox
XRX
$337M
| $938K | ﹤0.01% |
52,406
+40,439
| +338% | +$711K |
|
1469
EVgo
EVGO
$200M
| $937K | ﹤0.01% |
373,276
+332,281
| +811% | +$862K |
|
1470
MannKind Corp
MNKD
$1.28B
| $934K | ﹤0.01% |
206,189
+65,941
| +47% | +$259K |
|
1471
Schneider National
SNDR
$6.59B
| $934K | ﹤0.01% |
+41,235
| New | +$978K |
|
1472
Acadia Pharmaceuticals
ACAD
$4.25B
| $930K | ﹤0.01% |
50,301
+18,081
| +56% | +$448K |
|
1473
Franklin Resources
BEN
$16.9B
| $929K | ﹤0.01% |
33,033
-154,404
| -82% | -$4.25M |
|
1474
Simmons First National
SFNC
$3.35B
| $925K | ﹤0.01% |
47,537
-9,800
| -17% | -$186K |
|
|
GRP.U
1475
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $921K | ﹤0.01% |
16,117
-4,600
| -22% | -$256K |
|
Similar funds
Man Group's Q1 2024 Portfolio in Review
As of Q1 2024, Man Group held 2,331 positions worth $39.7B, up 10% from $35.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Man Group's Q1 2024 filing shows 307 new, 917 increased, 752 reduced and 230 closed positions. Its largest new stake was Planet Fitness: 865,365 shares worth $54.2M. The largest sale was NVIDIA, an estimated $236M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Man Group's largest Q1 2024 buy was Planet Fitness: 865,365 shares worth $54.2M.
- Man Group added most to Blackrock in Q1 2024, an estimated $174M increase.
- Man Group's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $236M.
- Man Group fully exited Invesco QQQ Trust in Q1 2024, selling an estimated $161M.
- Man Group's ten largest holdings make up 15% of its $39.7B portfolio in Q1 2024.
- Man Group opened 307 new positions and closed 230 in Q1 2024.
- Man Group's portfolio value rose 10% quarter-over-quarter to $39.7B.
Based on Man Group's 13F filing for Q1 2024, filed 15 May 2024.